We are live on
!
Find out more
VW
Vantage Wealth Portfolio holdings
AUM
$463M
1-Year Est. Return
18.98%
This Fund
S&P 500
This Quarter
Est. Return
+3.03%
1 Year Est. Return
+18.98%
3 Year Est. Return
+56.09%
5 Year Est. Return
+73.82%
10 Year Est. Return
+250.43%
AUM
$188M
AUM Growth
+$4.23M
(+2.3%)
Cap. Flow
-$3.09M
Cap. Flow
% of AUM
-1.65%
Top 10 Holdings %
Top 10 Hldgs %
46.16%
Holding
26
New
2
Increased
–
Reduced
22
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$7.38M |
| 2 |
Starbucks
SBUX
|
+$847K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$7.53M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
+$749K |
| 3 |
Apple
AAPL
|
+$200K |
| 4 |
Canadian National Railway
CNI
|
+$191K |
| 5 |
PepsiCo
PEP
|
+$185K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 22.61% |
| 2 | Technology | 17.41% |
| 3 | Industrials | 16.88% |
| 4 | Healthcare | 9.2% |
| 5 | Consumer Staples | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Visa
V
$679B
| $9.15M | 4.88% |
97,596
-1,650
| -2% | -$153K |
|
2
Wells Fargo
WFC
$261B
| $8.96M | 4.78% |
161,745
-3,410
| -2% | -$183K |
|
3
Novartis
NVS
$297B
| $8.89M | 4.74% |
118,871
-2,466
| -2% | -$175K |
|
4
Berkshire Hathaway Class B
BRK.B
$1.1T
| $8.75M | 4.67% |
51,660
-880
| -2% | -$146K |
|
5
JPMorgan Chase
JPM
$941B
| $8.62M | 4.6% |
94,320
-1,435
| -1% | -$124K |
|
6
Qualcomm
QCOM
$156B
| $8.6M | 4.58% |
155,687
-3,070
| -2% | -$172K |
|
7
Microsoft
MSFT
$3.39T
| $8.45M | 4.51% |
122,605
-1,270
| -1% | -$87.2K |
|
|
8
Apple
AAPL
$4.44T
| $8.4M | 4.48% |
233,432
-5,420
| -2% | -$200K |
|
|
9
Canadian National Railway
CNI
$77.3B
| $8.37M | 4.47% |
103,320
-2,500
| -2% | -$191K |
|
10
Johnson & Johnson
JNJ
$622B
| $8.37M | 4.46% |
63,274
-1,025
| -2% | -$131K |
|
|
11
PepsiCo
PEP
$191B
| $8.2M | 4.37% |
71,037
-1,610
| -2% | -$185K |
|
12
RTX Corp
RTX
$289B
| $8.16M | 4.35% |
106,164
-2,034
| -2% | -$152K |
|
13
3M
MMM
$90.9B
| $8.15M | 4.35% |
46,811
-1,065
| -2% | -$178K |
|
14
Welltower
WELL
$170B
| $7.36M | 3.93% |
98,345
-1,610
| -2% | -$118K |
|
|
15
IBM
IBM
$206B
| $7.2M | 3.84% |
+48,921
| New | +$7.38M |
|
16
United Parcel Service
UPS
$88.9B
| $6.97M | 3.72% |
63,055
-830
| -1% | -$88.7K |
|
17
Colgate-Palmolive
CL
$73.1B
| $6.97M | 3.72% |
94,017
-580
| -0.6% | -$43.1K |
|
18
T. Rowe Price
TROW
$24.1B
| $6.92M | 3.69% |
93,190
-900
| -1% | -$64.4K |
|
|
19
Starbucks
SBUX
$120B
| $816K | 0.44% |
+14,000
| New | +$847K |
|
|
20
Biogen
BIIB
$30.2B
| – | – |
-27,549
| Closed | -$7.53M |
|
|
BIVV
21
DELISTED
Bioverativ Inc. Common Stock
BIVV
| – | – |
-13,759
| Closed | -$749K |
|
Similar funds
CAM
CIP
MG
VFPW
HFA
STS
KK
GFA
Vantage Wealth's Q2 2017 Portfolio in Review
As of Q2 2017, Vantage Wealth held 26 positions worth $188M, up 2.3% from $183M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Vantage Wealth's Q2 2017 filing shows 2 new, 22 reduced and 2 closed positions. Its largest new stake was IBM: 48,921 shares worth $7.2M. The largest sale was Biogen, an estimated $7.53M.
By sector, the portfolio is most concentrated in Financials at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.
- Vantage Wealth's largest Q2 2017 buy was IBM: 48,921 shares worth $7.2M.
- Vantage Wealth's biggest Q2 2017 reduction was Apple, cutting an estimated $200K.
- Vantage Wealth fully exited Biogen in Q2 2017, selling an estimated $7.53M.
- Vantage Wealth's ten largest holdings make up 46% of its $188M portfolio in Q2 2017.
- Vantage Wealth opened 2 new positions and closed 2 in Q2 2017.
- Vantage Wealth's portfolio value rose 2.3% quarter-over-quarter to $188M.
Based on Vantage Wealth's 13F filing for Q2 2017, filed 15 Aug 2017.